Xenografting pig fetal ventral mesencephalic (pfVM) cells to repair the dopamine deficit in patients with Parkinson's disease is the focus of both experimental and clinical investigations. Although there have been marked advances in the experimental and even clinical application of these xenogeneic transplantations, questions regarding the host's xenospecific immune response remain unanswered. It has been shown that human serum is able to lyse pfVM tissue by both anti-gal-gal and non-anti-gal-gal antibodies by complement activation. The aim of this study was to investigate whether interindividual differences exist in the levels of pfVM cell-specific IgM and IgG subclass antibodies, their ability to lyse pfVM cells in vitro and the relationship between both. Pig fetal VM cells were incubated with heat-inactivated serum from 10 different individuals and binding of IgM antibodies and IgG subclass antibodies to pfVM cells was analyzed by flow cytometry. The ability to lyse pfVM cells was analyzed exposing 51 Cr-labeled pfVM cells to fresh serum or isolated IgM and IgG from the same individuals and subsequent determination of released 51 Cr from lysed cells. Strong differences were found between individuals in the levels of pfVM cell-specific IgM antibodies: antibody levels differed up to 40-fold. pfVM-specific IgG1 and IgG2 levels were only detectable in a few individuals. The ability to lyse pfVM cells ranged from negligible lysis up to 66.5% specific lysis. There was a strong correlation between the levels of individual pfVM-specific IgM antibodies and the ability to lyse pfVM cells in vitro. Isolated IgM, but not IgG, was able to lyse pfVM cells in the presence of complement. In conclusion, the interindividual differences in the levels of IgM with affinity for pfVM cells and their ability to lyse pfVM cells in vitro are considerable. Only few individuals possessed IgG1 and IgG2 subclass antibodies with affinity for pfVM. These findings may influence patient selection for porcine transplants and chances of graft survival in individual patients.
INTRODUCTION
practical, ethical, and possibly infectious difficulties associated with its use (5, (10) (11) (12) (13) 17, 18, 23) . There have Cellular transplantation to repair the dopamine deficit been marked advances in the experimental and even in patients with Parkinson's disease using fetal dopaclinical application of these xenogeneic transplantations menergic tissue has been the focus of both experimen- (4, 6) . However, many questions remain unanswered, estal and clinical investigations for over three decades pecially those regarding the host's immune response and (3, (7) (8) (9) 19, 24) . The possible usage of pig fetal ventral in particular the role of xenospecific "natural antibodies" mesencephalic (pfVM) tissue as a donor source has been against an intracerebral xenogeneic implant. investigated to overcome the limited availability of abor-Human serum is toxic to pig cells but different hution-derived human fetal dopaminergic tissue as well as man individuals show considerable quantitative differ-632 KOOPMANS ET AL. ences in their ability to lyse adult, nonneural porcine tion of 0.5 mg/ml IgM and 4 mg/ml IgG to avoid influence of individual antibody levels. tissue by complement activation (21) . Toxicity to pfVM tissue has been demonstrated for pooled human serum and was found to be mediated not only by anti-gal-gal Determination of Cytotoxicity antibodies but also by non-anti-gal-gal antibodies (22) .
The ability of sera to lyse pfVM cells was analyzed The aims of this study were to investigate: 1) whether by exposing 51 Cr-labeled pfVM cells to fresh serum and interindividual differences exist in the ability to specifisubsequent determination of released 51 Cr from lysed cally lyse pfVM cells in vitro, 2) the serum levels of cells. To label pfVM cells with 51 Cr approximately 20 pfVM cell-specific IgM and IgG subclass antibodies, million cells were incubated with 51 Cr (200 µCi) in 100 and 3) the relationship between the toxicity of sera to µl PBS for 60 min at 37°C. Cells were subsequently pfVM and serum levels of pfVM cell-specific IgM and washed with AIM-V medium and albumin (9:1) three IgG.
times before being centrifuged for 5 min at 1800 rpm and resuspended in 1 ml AIM-V. The suspension was MATERIALS AND METHODS diluted to 5 × 10 4 cells/ml and plated at 100 µl/well in a Antibodies and Reagents 96-well plate (Costar). Next, 100 µl/well of prediluted Affinity chromatography used anti-human IgM agarserum, IgM/IgG subfractions, and/or rabbit complement ose (Sigma, A9935) and MabTrap GII kit (Pharmacia was added at twofold dilutions. Alternatively, fresh hu-Biotech, 17-1128-01). Complements were Cedarlane CL3335 man serum deficient of pfVM-specific IgM and IgG was Low-tox-H rabbit complement and Biotest 824050 used as a complement source. Maximum 51 Cr release Complement. The medium used was AIM-V Gibco.
was determined adding Triton X-100 and background Fluorescent antibodies used were goat anti-human-IgMrelease adding AIM-V. After 60 min at 37°C the super-FITC (Protos) dilution 1:40; mouse anti-human-IgG1natant was removed and released 51 Cr was measured us-FITC (Zymed) dilution 1:20; mouse anti-human-IgG2ing a Packard gamma counter. The percentage specific FITC (Zymed) dilution 1:20; mouse anti-human-IgG3-FITC lysis was calculated as the measured minus background (Zymed) dilution 1:20; mouse anti-human-IgG4-FITC (Zyrelease divided by the difference between maximum and med) dilution 1:20; and mouse anti-human-IgG-FITC background release. All measurements were performed (Sigma) dilution 1:10.
in triplets and data are expressed as mean values.
Isolation and Preparation of Fetal VM Tissue
Binding of Antibodies to pfVM Porcine fetuses were obtained from anesthetized 28-To investigate the binding of different human immuday pregnant cross-bred Dutch Yorkshire Landrace pigs noglobulin classes and subclasses to pfVM cells, cells by hysterotomy and the VM was immediately microwere incubated with heat-inactivated serum from 10 difscopically dissected as previously described (11, 17, 23) . ferent individuals. Binding of IgM antibodies and IgG The VM was then cut into six to eight small pieces and subclass antibodies was analyzed by flow cytometry. stored in saline for 2 h at 4°C before being processed More specifically, cells were incubated with serum for into a single cell suspension (14) . Viability was assessed 30 min at 37°C and subsequently washed three times using the trypan dye exclusion test and viability was exwith HBSS. Next, the cells were incubated for 30 min pressed as percentage of viable cells with respect to the at 4°C with Ig class or subclass-specific fluorescent antitotal number of cells.
bodies. Cells were subsequently washed twice with HBSS and analyzed on a flow cytometer (Coulter Epics Elite).
Human Serum and Immunoglobulin Purification
To allow comparison of individual sera, measurements Human serum was obtained from 10 healthy volunwere done in one run with fixed settings of the flow teers. None of the individuals was ever directly exposed cytometer. Binding of pfVM-specific antibodies was exto porcine antigens (i.e., porcine insulin) or worked on pressed as the percentage of positive cells. Five percent a pig farm. All individuals ate (pig) meat. The serum or more positive cells was considered confident eviwas either used fresh or heat inactivated and stored at dence for the presence of pfVM-specific antibodies. −20°C until later use. Purified IgM and IgG was obtained from the sera by affinity chromatography using Statistics anti-human IgM agarose and MabTrap GII kit following the manufacturer's instructions. The concentration of the Statistical analyses were performed using GraphPad Prism version 3.00 for Windows (GraphPad Software, purified IgM and IgG in the individual solutions after purification was determined using the Dade Behring San Diego, CA). A Spearman test was performed to calculate correlation. BN2 and subsequently diluted to a standard concentra- 
RESULTS

Individual Differences in Human pfVM-Specific Antibodies
Interestingly, strong differences were found between individuals in the levels of mainly IgM class pfVM cellspecific antibodies as was indicated by flow cytometry analysis of binding of human antibodies to pfVM: antibody levels differed up to 40-fold. All but one sera contained pfVM cell-specific IgM antibodies, while two sera additionally contained small amounts of pfVM cellspecific IgG2 subclass antibodies (sera 1 and 9) and three sera contained pfVM-specific IgG1 subclass antibodies (sera 1, 5, and 9) ( Fig. 1) .
Individual Serum Levels of pfVM-Specific IgM Correlates With Ability to Lyse pfVM
The ability to lyse pfVM cells was present in almost There was a strong correlation between individual serum levels of pfVM-specific IgM antibodies and the ability to lyse pfVM cells in vitro (r = 0.93, p = 0.0002, cific lysis (1:4 dilution) was found ( Fig. 4) . Heat-inacti-Spearman correlation) ( Fig. 3) .
vated rabbit serum did not kill pfVM cells (Fig. 4) . As an alternative to rabbit complement we used serum from Rabbit Serum as a Complement Source donor 3 as a complement source (Fig. 4 ).
Toxic to pfVM Cells
Isolated IgM and Not IgG Toxic to pfVM Cells In our experiments testing isolated IgM and IgG from in the Presence of Complement different donors for cytotoxicity using rabbit serum as a complement source, we found that rabbit serum from
The ability of isolated IgM from different individuals to lyse pfVM cells showed marked individual differ-different sources is toxic to pfVM cells. Up to 63% spe- Figs. 1 and 2) . To test whether individual 3 could serve as a complement source, decomplemented serum from individual 1 ("high IgM") was mixed with fresh serum from individual 3 ("low IgM"). Data show that the rabbit complement we used is toxic to pfVM cells and that this toxicity is complement dependent because heat-inactivated serum does not kill pfVM cells. Mixing heat-inactivated serum from individual 1 (in itself nontoxic to pfVM) with fresh serum from individual 3 (nontoxic to pfVM cells), 63% specific lysis was measured, decreasing with further dilution of serum from individual 1. Based on these data we used individual 3 as an alternative complement source for further experiments with either isolated IgM or IgG. ences as observed with fresh serum, ranging between lysis of donor cells by complement activation. Sumitran et al. demonstrated that pooled human AB serum con-not detectable and 24.1% specific lysis (Fig. 5A ). There was a strong correlation between fresh serum and iso-tains IgG and IgM antibodies directed against galα1,3gal as well as non-gal epitopes on pfVM tissue, and that lated IgM in the ability to lyse pfVM cells in vitro (r = 0.68, p = 0.347, Spearman correlation). However, isolated human serum as well as human serum depleted of α-gal antibodies is able to lyse pfVM cells by complement IgM showed a decrease in the percentage of specific lysis compared with fresh serum. The ability of isolated IgG activation (22). In their studies they showed that both isolated IgG and IgM are cytotoxic to pfVM cells in the to lyse pfVM cells never exceeded 5.8% specific lysis and should be considered negative (Fig. 5B) .
presence of complement (22) . In contrast, we could not demonstrate cytotoxicity of isolated IgG to pfVM.
DISCUSSION
Pooled serum as was used by Sumitran et al. perhaps contains serum from an individual with high IgG levels Our results show that most human serum is able to lyse pig fetal ventral mesencephalic cells by way of with affinity for pfVM. We do not think that our results are influenced by the use of fresh serum from a donor complement activation. There are however large differences in the extent to which these sera are able to lyse without IgM with affinity for pfVM instead of rabbit complement, although it cannot be excluded. pfVM cells. In the sera used for this study, specific lysis of pfVM ranged from negligible lysis up to 66.5% at Differences between human sera in their toxicity to pfVM are significant. In our study, lysis of pfVM cells 1:4 serum dilutions. There was a strong correlation between the amount of IgM class antibodies with affinity by human serum differed from 0 to 66.5% specific lysis. Schaapherder et al. tested a large series of different hu-for pfVM and the ability to lyse pfVM in the respective sera. We found only very low levels of IgG subclass man donors and found substantial interindividual differences in both toxicity against nonneural tissue [porcine antibodies with affinity for pfVM in a minority of donors, and were not able to show IgG-induced lysis of endothelial cells (PEC) and porcine islet cells (PIC)] (61% specific lysis average, range 38-81%; n = 30) and pfVM by complement activation.
Xenoreactive antibodies have been shown to cause the amount of antibodies directed against nonneural por- cine cells (20, 21) . Importantly, they demonstrated that In vivo studies have shown that there may be an important role for antibodies and complement in the re-agammaglobulinemic sera killed approximately 42% of PIC (21), suggesting complement activation via the al-jection of an intracerebral xenograft, both indirectly by facilitating a cellular response, and directly via comple-ternative pathway. In contrast, we found no indication of the latter, as serum without IgM directed against ment activation and subsequent cell death (1, 2, 15, 16) . Acknowledging these findings, our data, showing con-pfVM gave no detectable lysis of pfVM. Further, there was a strong correlation between the individual serum siderable differences between different human individuals in levels of (primarily) IgM class antibodies directed levels of pfVM-specific IgM antibodies and the ability to lyse pfVM cells in vitro, suggesting complement ac-against pfVM cells and their ability to lyse pfVM cells via complement activation, can in our opinion have clin-tivation via the classical pathway. This may indicate that transplantation of neural tissue is safe with respect ical significance in terms of patient selection for porcine transplants and chances of graft survival in individual to activation via the alternative complement activation pathway.
patients.
